Table of Contents
Table 5-83: Vermillion
Table 5-85: Wabash
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 305 | 670.4 | 1,407 | 617.5 | 146 | 325.2 | 670 | 303.2 |
| Esophagus | 6 | 14.1** | 23 | 10.0 | * | # | 12 | 5.1** |
| Stomach | * | # | 13 | 5.7** | * | # | 6 | 2.6** |
| Colon excluding Rectum | 20 | 45.9 | 121 | 53.6 | 21 | 47.8 | 83 | 37.0 |
| Rectum and Rectosigmoid Junction | 13 | 26.0** | 55 | 23.8 | * | # | 13 | 5.8** |
| Liver | 5 | 10.3** | 18 | 7.9** | 5 | 11.1** | 13 | 5.9** |
| Pancreas | 7 | 16.4** | 33 | 15.3 | 5 | 11.3** | 32 | 15.1 |
| Lung and Bronchus | 62 | 136.7 | 295 | 130.1 | 55 | 119.3 | 271 | 121.9 |
| Melanoma of the Skin | 12 | 26.7** | 37 | 15.9 | * | # | 8 | 3.4** |
| Prostate | 79 | 175.6 | 350 | 153.5 | 11 | 24.9** | 51 | 25.3 |
| Urinary Bladder | 19 | 42.4** | 99 | 44.5 | * | # | 11 | 5.2** |
| Kidney and Renal Pelvis | 5 | 9.0** | 41 | 18.2 | 7 | 15.1** | 18 | 7.9** |
| Brain and Other Nervous System | * | # | 18 | 7.6** | * | # | 12 | 5.2** |
| Non-Hodgkin Lymphoma | 7 | 14.4** | 48 | 21.0 | * | # | 26 | 11.3 |
| Myeloma | * | # | 15 | 6.5** | * | # | 13 | 5.9** |
| Leukemia | 14 | 33.3** | 44 | 19.2 | 8 | 18.3** | 24 | 10.9 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 245 | 382.9 | 1,402 | 435.7 | 121 | 178.3 | 612 | 176.6 |
| Colon excluding Rectum | 20 | 26.6 | 144 | 40.1 | 13 | 19.0** | 62 | 17.4 |
| Rectum and Rectosigmoid Junction | 7 | 10.4** | 36 | 11.1 | * | # | 6 | 1.8** |
| Liver | * | # | 9 | 2.5** | * | # | 6 | 1.4** |
| Pancreas | * | # | 24 | 6.4 | * | # | 25 | 6.6 |
| Lung and Bronchus | 46 | 66.4 | 217 | 65.9 | 40 | 60.8 | 176 | 52.9 |
| Melanoma of the Skin | * | # | 37 | 13.7 | * | # | 3 | # |
| Breast | 69 | 118.2 | 409 | 130.9 | 16 | 25.5** | 94 | 28.6 |
| Cervix Uteri | 5 | 9.0** | 18 | 6.2** | * | # | 14 | 4.8** |
| Corpus Uteri | 13 | 21.0** | 79 | 27.2 | * | # | 7 | 2.1** |
| Ovary | 8 | 12.7** | 43 | 13.3 | 9 | 14.2** | 34 | 10.3 |
| Urinary Bladder | 7 | 10.6** | 36 | 10.9 | 6 | 7.0** | 12 | 3.1** |
| Kidney and Renal Pelvis | 7 | 11.2** | 38 | 12.8 | * | # | 12 | 3.6** |
| Brain and Other Nervous System | 6 | 10.7** | 22 | 8.1 | * | # | 3 | # |
| Non-Hodgkin Lymphoma | 10 | 15.2** | 49 | 14.9 | * | # | 24 | 6.4 |
| Myeloma | * | # | 23 | 6.5 | * | # | 12 | 3.0** |
| Leukemia | * | # | 30 | 8.4 | 6 | 8.0** | 27 | 7.1 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-83: Vermillion
Table 5-85: Wabash
